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The advancement of human performance benefits from state-of-the-art technology to improve 
the ability to monitor and evaluate physiological adaptations in athletes. Previously validated as a 
reliable tool for measuring muscle oxygenation, near-infrared spectroscopy (NIRS) has evolved into 
a more portable platform capable of being used in a variety of settings. One such example of a 
portable NIRS device advertised to athletes and the military is the MOXY monitor. 
 
Purpose: To our knowledge, no studies exist that have examined the output produced by the MOXY 
monitor compared to other more established variables during high intensity intervals. Therefore, the 
purpose of this experiment was to evaluate the output provided by the MOXY monitors (SmO2) by 
comparing SmO2 to more established exercise variables including VO2, heart rate and blood lactate 
(BL) to determine if the values agree with physiological expectations. We predicted that the SmO2 
would demonstrate an inverse relationship to other measured variables including HR, VO2 and BL. 
Eg. As SmO2 decreased, HR, VO2 and BL would increase and peak HR, VO2,BL values would 
coincide with SMO2 troughs. Methods: Six endurance-trained East Carolina University students, 
aged 21±2 years completed a VO2 max test followed by 6 high-intensity 30-second sprint intervals at 
125% of VO2 max wattage on a cycle ergometer. SmO2 was measured using MOXY monitors 
(Fortiori Design LLC., MN, USA) placed on the quadriceps 
 
muscles as well as the left deltoid. HR was monitored using a Garmin FR70 watch (Garmin Ltd., 
Switzerland) and VO2 obtained using a Parvomedic TrueOne 2400 metabolic cart (Parvo Medics, 
UT, USA). BL was collected within 5 seconds of the completion of each of the 6 high intensity 
intervals using a Lactate Plus Meter (Sports Research Group Inc.). SmO2 and VO2 and SmO2 and 
HR were plotted over time to present a graphical illustration demonstrating the relationships among 
changes in oxygen saturation and the change with VO2 and HR. BL and SmO2 were presented using 
tables to display changes in BL and SmO2 as the intervals progressed. Results: All participants had a 
VO2 max >30ml/kg/min and no musculoskeletal injuries in the previous 3 months were reported. 
During each of the six intervals, SmO2 was shown to decrease as both VO2 and HR increased. 
Troughs in SmO2 did not consistently align with peaks in VO2 and HR, as SmO2 tended to reach 
troughs about 10 seconds after the completion of many intervals. VO2 demonstrated peaks at 20 and 
40-seconds following interval completion. Patterns in BL were unable to be evaluated due to 
inadequate BL collection. Three participants demonstrated a pattern of increasing BL with intervals 
1-4 followed by a plateau or decline in the final intervals. 
 
Conclusion: The findings from this study support the hypothesis that SmO2 would demonstrate 
an inverse relationship compared to HR and VO2 during high intensity intervals. e.g. As SmO2 
decreased during the intervals, both HR and VO2 increased. Peak HR and VO2 values did not 
coincide with SmO2 troughs. A delay of about 10 seconds was observed in SmO2 troughs and a 
20 to 40-second delay was seen in peak VO2 and HR values. The results obtained from this 
study suggests the MOXY monitors may provide reliable output as the inverse relationships 
among SmO2 and HR and SmO2 and VO2 agree with physiological expectations, despite peaks 
and troughs not coinciding. Further research will be needed to explore the relationships among 
these variables and to further assess the MOXY monitor as a tool for exercise training. 
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Chapter 1: Introduction 
 
The field of human performance relies on technological advancements in exercise monitoring 
to guide training regimens in order to push the capabilities of the human body to perform at the 
highest level. There are many technologies available to monitor training adaptations in athletes of 
all levels with the goal of increasing performance, longevity and recovery. Two established exercise 
tools include the heart rate (HR) monitor and the metabolic cart, used to measure heart rate and 
oxygen consumption (VO2), respectively. 
 
A lesser used technology continuing to be explored for its potential as an exercise training 
tool is near-infrared spectroscopy (NIRS). NIRS has been validated for its ability to accurately 
measure changes in oxygenation both in the brain as well as within skeletal muscle for quite some 
time (Mancini et al., 1994). NIRS uses near-infrared light, between 600-1,000 nanometers to 
penetrate the capillaries within muscle tissues. It was discovered that when near-infrared light was 
shown into body tissues, differences were observed in the absorbency of oxygenated and 
deoxygenated hemoglobin and myoglobin (Bellardinelli et al., 1995). NIRS measures the amount of 
near-infrared light that is reflected to a detector after being shown into the muscle and partially 
absorbed based on the amount of hemoglobin and myoglobin that is oxygenated. Calculations are 
then used by the various monitors to estimate a percentage of hemoglobin and myoglobin that is 
oxygenated, termed muscle oxygenation. Initially used in the clinical setting to measure 
oxygenation within the brain, NIRS technology was quickly adopted into the field of exercise 
science as a potential route for monitoring changes in skeletal muscle oxygenation during exercise. 
 
The ability for NIRS to measure changes in muscle oxygenation has been validated, as 
demonstrated in studies by Grassi et al. (1999), Shibuya et al. (2003), and Tachi (2004) and 
summarized in a NIRS review by Bhambhani et al. (2004). Previous research has examined muscle 
 
oxygen saturation during incremental exercise as well at higher intensities. During incremental 
exercise, Bellardinelli et al. (1995) found skeletal muscle oxygen decreased progressively 
throughout testing and was most desaturated at around 80% of VO2 max. Bellardinelli concluded 
that NIRS is a noninvasive method of monitoring skeletal muscle changes in oxygenation during 
incremental exercise. Additionally, Bhambhani’s 2004 review supports the effectiveness for NIRS 
technologies to measure muscle oxygen trends during both incremental aerobic exercise as well as 
anaerobic exercise. 
 
As NIRS has become more widely explored for its applications in exercise, more portable 
NIRS devices have become a focus among the commercial market. A portable and wireless NIRS 
monitor, and the one chosen for this study, is the MOXY monitor. It is small and economically 
priced for the everyday consumer, unlike many NIRS instruments that are bulky and expensive. 
MOXY uses four light emitting diodes that shine near-infrared light into the muscle tissues which is 
then reflected to two detectors, distinguishing it from other devices with a single detector. A series 
of calculations and algorithms are then used by the monitor to estimate a percentage of hemoglobin 
and myoglobin that is oxygenated, coined skeletal muscle oxygen saturation (SmO2). Little 
research has been published examining the SmO2 output provided by the MOXY monitor. Some 
available studies using MOXY monitors have examined the reoxygenation of forearm muscles in 
rock climbers and lower extremity oxygenation after low-intensity training in older adults (Bau et 
al., 2015 & Balas et al., 2015). 
 
Similar to the MOXY monitor is another wireless NIRS device known as the PortaMon. 
(Artinis Medical Systems, Netherlands). Jones et al. (2015) examined muscle oxygen using the 
PortaMon in Olympic caliber field hockey athletes during a 6-week sprint interval cycling protocol. 




studies by Miura et al. (2000) and Grassi et al. (1999) found correlations between muscle 
oxygenation and VO2 and blood lactate. Grassi found that as blood lactate accelerated, muscle 
oxygenation decreased. Examining muscle deoxygenation during sprints on a cycle ergometer, 
Racinais et al. (2007) also demonstrated a decrease in oxygenation coinciding with an increase in 
VO2 following 6-second sprints and 30-second rests. 
 
To our knowledge, no published research has been conducted using the MOXY monitors to 
measure SmO2, VO2, heart rate and blood lactate during high intensity intervals. The purpose of 
this experiment was to evaluate the output provided by the MOXY monitors (SmO2) by comparing 
SmO2 to more established exercise variables including VO2, heart rate and blood lactate (BL) to 




1) SmO2 measured by the MOXY monitors during high intensity intervals will show an 
inverse relationship with heart rate. Eg. SmO2 will decrease during the intervals while HR 
rises. Troughs in SmO2 will correspond to peaks in HR. 
 
2) SmO2 measured by the MOXY monitors during high intensity intervals will illustrate an 
inverse relationship with VO2. Eg. SmO2 will decrease during the intervals while VO2 
increases. SmO2 troughs will correspond to peaks in VO2. 
 
3) SmO2 measured by the MOXY monitors during high intensity intervals will decrease with 




Age- Age of subjects ranged from 18-23 years 
 







Intensity of Cycling During Intervals- The intensity for intervals was set at 125% of max 
power wattage and rest periods were set at 20% 
 
Duration of Interval- 30-second intervals were chosen based on the recommendation of 
Chuck Tanner (Professor at ECU in the Dept. of Kinesiology) 
 
Duration of Rest Between Intervals- 90-second rest periods were chosen based on the 




Desired Cycling Wattage- The cycling ergometer consistently took between 10-15 
seconds to achieve desired wattage for the high intensities for the participants with the 
highest power wattages. Therefore, cycling time under desired wattage was limited 
 
Blood Lactate Collection- BL readings were limited by sweat and calloused hands 
 
Loss of signal from MOXY Monitors- Output provided by the MOXY monitors were 
unavailable for some time periods 
 
Unusually high SmO2- Output provided by the MOXY monitors showed alarmingly 




























Advancement in exercise technology is central to the optimization of training in athletes. 
In the last 100 years, many advances have been made in exercise monitoring that have broadened 
the scope of available biological data. Examples include the measuring of heart rate using 
wireless monitors, volume of oxygen consumed (VO2) using metabolic carts and blood lactate 
using a variety of lactate meters. Today, there are many exercise technologies available to all 
levels of athletes, with the ability to monitor steps, heart rate, calories burned, and distance 
traveled. These have been made readily available by companies such as Fitbit, Garmin and 
Jawbone. With the level of sports performance continually increasing, a high demand has been 
created for technology companies to produce even greater advancements in wearable exercise 
tools to optimize training. 
 
It wasn’t until the 1980’s that wireless heart rate monitors became available for everyday 
consumers, creating a surge in popularity (Achten et al. 2003). The ability for heart rate monitors 
to measure heart rate has long been validated. Today, they are a staple among researchers and 
exercisers to monitor and optimize training and improve performance. Heart rate can directly be 
used as an indicator of exercise intensity and is often manipulated for training in certain ‘heart 
rate zones’ to elicit a desired training adaptation. The American Council of Sports Medicine has 
even used heart rate to develop general classifications of physical activity using percentages of 
maximum heart rate (Pollock et al., 1998). Recently, heart rate variability (HRV) has gained 
popularity as it may be a better indicator than sole heart rate for overall training status and health. 
A study by Tsuji et al. (1994) found that high HRV was associated with higher VO2 max while 
lower HRV was associated with increased mortality. To explain the impact an exercise tool may 
 
have on advancing the world of sports performance requires looking no further than the heart 
rate monitor. 
 
A newer exercise tool growing in popularity since transitioning into a more portable 
platform is near infrared spectroscopy (NIRS), a noninvasive method developed to assess 
changes in oxygenation within skeletal muscle. The development of NIRS as an exercise tool is 
credited to Glenn Allan Millikan who was the first to use a dual wavelength oximeter to assess 
oxygen within muscle (Mozina et al., 2011). It was Frans Jobsis who in 1977, made the 
observation that near-infrared light acted in a transparent manner when shown into body tissue 
and noted that the absorbency differed depending on the oxygenation of hemoglobin and 
myoglobin (Hamaoka et al., 2007). It is this difference in absorbency that allows NIRS 
technologies to distinguish between oxygenated/deoxygenated hemoglobin and myoglobin 
within muscle tissues. NIRS works by shining near-infrared light between 600-1,000 nanometers 
into muscle tissue. The reflected light is then returned to a detector(s) where a series of 
algorithms and calculations produce a useable estimation of muscle oxygen saturation. The Beer-
Lambert law provides the mathematical basis for NIRS, which states “that light passing through 
a solution of colored compound is absorbed by the compound, resulting in reduction in intensity 
of emerging light” (Mozina et al., 2011). This is an integral component for calculations in all 
NIRS instruments as many devices have altered this equation to claim greater measurement 
precision. Additional calculations are added to account for various issues such as the scattering 
of light caused by adipose tissue. The number of light sources as well as the number of detectors 
may differ slightly among NIRS instruments. Early models of NIRS used a single-distance 





Original NIRS instruments were used to assess oxygenation within the brain and were 
quite large, expensive and immobile. More portable models were later created for more dynamic 
use but still required wires and a control box, restricting its use to the laboratory (Hamaoka et al., 
2011). In recent years, wireless NIRS monitors have been developed to offer the user free rein to 
be used in a variety of settings. Two such monitors are the PortaMon (Artinis Medical Systems, 
Netherlands) and the MOXY monitor (Fortiori Design, LLC, Minnesota) and allow researchers 
to openly explore muscle oxygen saturation during an array of exercises including running, 
cycling, hiking, swimming as well as during sport. The PortaMon and MOXY are similar in that 
they are both portable, wireless monitors that are attached directly to the skin of the testing 
muscle and transmit muscle oxygen estimations via Bluetooth directly to a software database 
provided with purchase. These monitors are marketed to a wide population including researchers, 
recreational exercisers, as well as elite athletes. Like all NIRS instruments, the two devices differ 
in the number of lights and detectors as well as mathematical estimation of muscle oxygenation. 
MOXY uses 4 light emitting diodes as well as two detectors, distinguishing it from other single 
light diodes with one detector. Like most NIRS instruments, both the PortaMon and MOXY use 
the Beer-Lambert law in their calculations; however, many companies choose to modify the 
equation, attempting to correct for possible scattered light caused by adipose tissue between the 
skin and muscle. With this new-found portability, NIRS has emerged as a potential frontrunner 
in exercise monitoring. 
 
NIRS in the Literature 
 
Since its adoption as an exercise tool, the ability for NIRS to observe changes in muscle 
oxygenation has been well examined. Few studies have been published using MOXY monitors. 




and the effects of low-intensity exercise training on muscle strength and oxygenation in older 
adults. Bau et al. (2015) found that a 6-week training program in older adults in community 
dwellings counterbalanced the muscular function decline seen in the control group. Balas et al. 
(2015) assessed the effects of different recovery techniques during rock climbing on forearm 
reoxygenation It was found using MOXY monitors that shaking the forearm beside the body 
allowed for greater reoxygenation and recovery between climbs. These studies demonstrate the 
potential applicational use MOXY monitors may have in exercise monitoring. 
 
In addition to its use as an exercise tool, NIRS has often been used in the clinical setting. 
A study by Wilson et al. (1989) found that the range of 760-800 nanometers proved to correlate 
closely with venous hemoglobin oxygen saturation. To assess the ability for NIRS to detect flow-
related changes in hemoglobin and myoglobin, this same range of near-infrared light was used to 
assess oxygen saturation in the vastus lateralis muscle during progressive cycling exercise in 
both normal subjects as well as those with heart failure. This study found a lower oxygenation 
among the heart failure patients and suggested NIRS as a method to detect impaired oxygen 
delivery in patients with heart failure. In estimating muscle oxygen during incremental exercise, 
Bellardinelli et al. (1995) found that oxygen saturation decreased with incremental exercise. 
During progressive workloads on a cycle ergometer, a slow decrease in oxygen saturation was 
observed followed by a more rapid decrease around the lactate threshold and a plateau of 
minimum saturation point around 80% VO2 max. Works by Bellardinelli et al. (1995) and 
Bhambhani et al. (1997) demonstrated a four-phase oxygen saturation trend consistently 
observed during incremental exercise. At the onset of exercise, an initial increase in muscle 
oxygen saturation is seen, followed by a decrease below resting baseline with increased work 




increase in saturation during the 1-2 minutes following exercise. Additionally, Neary et al. 
(2001) found that longer duration exercise elicited greater deoxygenation of hemoglobin and 
myoglobin. 
 
NIRS technology has also been utilized during high intensity exercise. Racinais et al. 
(2007) assessed muscle oxygen patterns during ten 6-second sprints with 30-second rests using a 
cycle ergometer. Significant muscle deoxygenation was observed during repeated sprints 
alongside a significant increase in VO2. In another study using 30-second high-intensity Wingate 
tests on a cycle ergometer, Bae et al. (2000) found a decline in vastus lateralis muscle oxygen 
between seconds 3-15, with a plateau occurring after 15 seconds. The ability for NIRS to 
measure muscle oxygen patterns has been well covered in review papers by Bambhani et al. 
(2004) and Hamaoka et al. (2011). 
 
In addition to examining muscle oxygenation patterns, NIRS has also been used to 
compare to other more established exercise measurements. Several studies have found an inverse 
relationship among muscle oxygen saturation and oxygen consumption (VO2). As previously 
mentioned, Racainas found an inverse relationship during repeated sprint tests. As muscle 
oxygen decreased, VO2 was found to increase. A 2003 study by Shibuya et al. examined the 
relationship between muscle oxygenation and VO2 max during incremental cycling. It found that 
a significant relationship existed between the percentage of muscle oxygenation and VO2 max. 
Shibuya also suggested that muscle oxygenation using NIRS technology could be a predictor of 
muscle oxygen diffusion capacity since the diffusion of muscle oxygen is a limiting factor for 
VO2 max. In an earlier study by Tesch et al. (1985), beta-blockers were used to lower heart rate 
in participants, thereby lowering VO2. Results found that oxygenation decreased, suggesting a 




The relationship between muscle oxygenation and blood lactate has also been examined. 
Studies have found that muscle oxygenation decreases as blood lactate increases. Grassi et al. 
(1999) found significant correlations between the onset of lactate acceleration and the onset of 
muscle deoxygenation during incremental exercise. Balsom et al. (1994) also found that 
diminished oxygen availability resulted in greater accumulation of blood lactate. Bhambhani et 
al. (2004) demonstrated the correlation between lactate threshold and VO2 max. Bellotti et al. 
(2013) found that a plateau in muscle oxygenation correlated with maximum steady state while 
cycling and suggested muscle oxygen monitoring may be a better means for monitoring aerobic 
fitness than VO2 max due to the cost effectiveness and ease of use. Overall, the ability for NIRS 
to measure muscle oxygenation patterns and correlate these findings to other measurements 
including VO2 and blood lactate has been adequately examined. To date, no research exists in 




The purpose of this study was to assess the MOXY monitor as a potential exercise tool by 
evaluating SmO2 along with established exercise measurements including VO2, heart rate, and 
blood lactate and comparing to physiological expectations. This was done to establish 
relationships among the variables to explore the possibilities with NIRS technology. Our 
hypotheses were that heart rate and VO2 would increase to peak values during the 30-second 
intervals as SmO2 decreased to a trough. We also predicted that SmO2 would decrease as the 




The validity of NIRS has long been examined and has shown its ability to produce 




NIRS devices, the applications for use in exercise monitoring are numerous. Many papers have 
been written examining the output provided by various devices in a variety of settings. Studies 
have measured other parameters alongside muscle oxygen like VO2 and blood lactate and found 
inverse relationships. These findings suggest that SmO2 provided by the MOXY monitor may 


















































Chapter 3: Methods and Materials  
Participants 
 
The participants in this study were 6 endurance-trained East Carolina University students 
aged 18-23 years. Inclusion criteria included regularly engaging in endurance exercise for at least 
30 minutes a minimum of three times per week for the previous 6 months. Participants were also 
required to be between the ages of 18 and 30 years and have a minimum VO2 max of 
30ml/kg/min in the VO2 max test (maximum oxygen consumption in milliliters per kilogram per 
minute). Participants were excluded if they had a history of cardiovascular disease, bleeding 
disorders, or a musculoskeletal injury over the previous 3 months. Written voluntary consent was 
obtained from all participants, providing necessary information regarding the purpose, procedure 





This study was conducted in the Human Performance Laboratory (HPL) in room 363, located 
in the Ward Sports Medicine building at East Carolina University. The laboratory used was a 
biosafety level 2 certified laboratory. Participant’s full participation was 90-minutes or less and 
required just one visit. During this visit, participants completed questionnaires on training 
including related injuries, typical exercise duration and intensity as well as exercise classes taken 
in school. The dietary questionnaire included a frequency questionnaire in which it was recorded 
how many times in the past month, week or day the participant consumed a variety of foods as 
well as dietary supplements. 
 
VO2 max was assessed using a cycle ergometer to obtain a VO2 max value as well as a 
maximum wattage to later be used in calculating interval intensity for the participants. SmO2, 
HR, and VO2 were measured during the test as well as a BL measurement both before and after. 
 
Finally, six 30-second high-intensity intervals were done on the same cycle ergometer while 
SmO2, VO2, HR were measured. BL was obtained a total of six times during the intervals, 
occurring within 5 seconds after the end of each of the six intervals. Anthropometrics 
measurements, including height, weight, and skinfold thickness were taken for each participant, 




Participants completed questionnaires pertaining to training history, diet and supplement 
use. Examples of the training and dietary questionnaires can be found in appendix C. The 
training questionnaires provided information on the participant’s training regimen such as type of 
exercise, frequency, duration, and intensity. Questions also included history of endurance 
training, number of miles run per week, number of training injuries in the last 12 months, 
number of exercise courses taken in school, and musculoskeletal injuries in the previous 3 
months. The dietary questionnaire included a food frequency questionnaire in which participants 
responded with how many times per day or week they consumed the following foods: fruits, 
vegetables, whole grains, dairy, nuts, fish, poultry, lunch meats, pork and fish. The dietary 
supplement questionnaire included questions regarding frequency of use, including the following 
supplements: multivitamins, vitamin D, fish oil, protein powder, creatine/HMB, pre-workout 




Both height and weight were obtained using a Detecto medical scale (Detecto Scale 
Company, MO) located in the human performance laboratory. Body fat was obtained using 
skinfold calipers (Lange, HealthCheck Systems, NY) and the 7-site skinfold method according to 




attempt if there was greater than 2 cm difference between first two. Skinfold sites included 
triceps, chest, midaxillary, subscapular, suprailiac, abdominal, left thigh, and right thigh. All sites 
were taken in millimeters (mm). Calculations were done using the average between the left and 
right thigh measurements. Calculations for body fat were done using the Jackson and Pollock 
body density equation followed by the Siri equation (Jackson, A.S et al. 1978; Jackson, A.S et al. 
1980; Siri et al. 1961). 
 
Jackson and Pollock Equation: 
 
Males: Body Density = 1.112 – (.00043499 x sum of skinfolds) + (.00000055 x 
square of the sum of skinfold sites) – (.00028826 x age yrs) 
 
Females: Body Density = 1.097 – (.00046971 x sum of skinfolds) + (.00000056 x 




% Body Fat = (495/ body density) – 450 
 
Placement and Internal Calibration of The MOXY Monitor 
 
The MOXY monitor is a portable and wireless muscle oxygen monitor that uses near-
infrared spectroscopy to assess skeletal muscle oxygen saturation (SmO2) and total hemoglobin 
(THb) in a specific muscle during exercise. The equation for SmO2 can be written as follows: 
 
SmO2= Oxygenated hemoglobin and myoglobin Total 
amount of hemoglobin and myoglobin 
 
MOXY uses near-infrared light between 670 and 810 nanometers to penetrate the muscle 
fiber and based on differing absorbencies between oxygenated/deoxygenated hemoglobin and 
myoglobin, an algorithm is used to calculate a percentage of muscle that is oxygenated. 
(https://www.moxymonitor.com/) As a small portable device, the MOXY monitor is advertised 
as an exercise tool to be used to monitor adaptations in muscle oxygen saturation to improve 
14 
 
muscular aerobic capacity. The purchase of the monitor comes with a software program called 
Peripedal that collects, displays and stores data on a computer directly from the monitors in real 
time. 
 
Three MOXY monitors were used during testing and placed on the participants where 
they remained until all testing was completed. One monitor was placed on each subject’s left and 
right quadriceps. Using a tape measure to measure the distance between the patella and the hip, a 
marker was used to mark a midway point for the monitor to be placed. This was done on both 
quadriceps. The muscle most likely being measured based on placement was the rectus femoris. 
A third monitor was placed on the midway point on the left deltoid as a control for a non-
working muscle. The same monitors were used to measure the left and right quadriceps and 
deltoid for each subject to control for monitor variation. Each monitor was labeled with a 
manufacturer given number, with the three used in this study being 327, 524 and 525. Monitor 
number 327 was assigned to the left deltoid, monitor 524 to the subject’s left quadriceps and 525 
to the right quadriceps muscle. Each monitor was held to the skin using specific sticky pads that 
came with the purchase of each of the monitors. Black Powerflex tape was used to cover the 
monitors to ensure ambient light was unable to interfere with the monitor’s near-infrared light. 
The MOXY monitors provided wireless data on every interval through testing and these data 
were stored in the Peripedal program for analyzing. 
 
For the purpose of obtaining a minimum value for comparison with testing values, an 
occlusion calibration protocol was used on the monitors assigned to the participant’s quadriceps. 
A large manual blood pressure cuff was placed around the subject’s thigh, above the location of 
the MOXY monitor. The participant’s testing leg was slightly elevated, held up by the researcher 




SmO2 levels were monitored. Once SmO2 plateaued for greater than 30 seconds or the subject 
became too uncomfortable to continue, the calibration ended and the lowest SmO2 obtained was 
recorded. The procedure was completed on both legs. This procedure was recommended by 
Terence Ryan, an expert in NIRS technology who works at the ECU Heart Institute and 
specializes in NIRS technology and conduced similar procedures in previous research. (Ryan et 
al. 2013) 
 
VO2 Max Test 
 
The VO2 max protocol was adopted from the Storer Maximal Bicycle Test. (Storer et al. 
1990). Testing was conducted on a Corival cycle ergometer using a Parvo Medics TrueOne 2400 
metabolic cart. Standard facemask and VO2 testing equipment was used with the metabolic cart 
to obtain VO2 and the respiratory exchange ratio. Participant’s shoes were taped to the pedals of 
the cycle ergometer to prevent the pedal straps from coming undone due to the intensity of the 
cycling. 
 
Participants began the VO2 max test at 50 watts on the cycle ergometer and were 
instructed to maintain 70 rpms. The metabolic cart was connected to the cycle ergometer and 
pre-programmed to begin at 50 watts and automatically increase by 15 watts every 60 seconds. 
The test was terminated when the rotations per minute (rpms) fell below 70rpm. The last fully 
completed interval wattage was designated the maximum power wattage and subsequently used 
to calculate the interval intensities. VO2 max was calculated using ml/kg/min and provided by 
the metabolic cart. A 10-15-minute break was allowed between the VO2 test and the high-
intensity intervals. 
 
In addition to SmO2 and THb provided by the MOXY monitors, heart rate, VO2 and 




which was synced to the Peripedal program using ANT+ technology provided with the Garmin 
watch. Heart rate was displayed in the Peripedal program and stored with SmO2 and THb. The 
heart rate monitor used in this study contained a heart rate strap to be worn by all subjects during 
testing. The monitors were activated before testing and beats per minute were verified to be 
displayed on the laptop with SmO2 and hemoglobin before continuing. VO2 was measured by 
the metabolic cart and was taken every 20 seconds. The Parvo Medic metabolic cart was 
calibrated prior to participant testing following the standard Human Performance Lab 
Parvomedics instructions. 
 
Blood lactate was taken 30 seconds before testing began and immediately following 
testing using a Lactate Plus meter by Sports Resource Group, Inc. The meter used a single drop 
of blood on the end of a blood lactate strip, much like a diabetic checks their blood glucose. 
After the drop of blood was applied, the meter took 14 seconds to display the blood lactate 
reading. The principal investigator (PI) was the only researcher to conduct the blood lactate 
pricks. Blood absorbent cloths were places on the floor and around the cycle ergometer’s handle 
bars to catch possible stray blood drops. The PI wore an appropriate laboratory coat and did all 




Subjects completed six 30-second intervals with 90 seconds of rest between intervals. 
 
The intensities of the intervals were calculated based on the subject’s maximum wattage during 
the VO2 max test. The intervals were conducted using 125% of maximum wattage obtained in 
the VO2 max test, while the 90-second rests between intervals were done at 20% maximum 
wattage. All subjects began and ended the high-intensity intervals with a 90-second rest. The 




computer-generated protocol on the metabolic cart. Subjects were instructed to continue pedaling 
at all times and to pedal as hard as possible during the 30-second intervals with verbal 
encouragement. 
 
Heart rate, SmO2, THb, VO2 and blood lactate were measured during the interval testing. 
Blood lactate was taken immediately concluding each interval, totaling 6 blood lactate samples. 
A second attempt at obtaining a lactate reading was immediately used with the subject’s 





Data collected by the Peripedal program, including SmO2, THb and heart rate were 
converted using Peripedal into Microsoft EXCEL spreadsheets, with data values displayed 
against time. Time measured by the metabolic cart displaying VO2, and blood lactate 
documented by the researchers were matched manually to align with the time scale used by the 
Peripedal program. 
 
This pilot study was analyzed like a series of case studies to identify if the MOXY 
monitor output followed patterns of established physiological factors (VO2, heart rate, lactic 
acid). Graphs were created using Microsoft EXCEL for each participant. Line graphs were used 
to illustrate the change in measurements over time. A figure was created for each subject to 
display SmO2 and THb over time, each with its own y-axis, and time displayed on the x-axis. 
Another figure was created for each subject with SmO2 and VO2 having their own y-axis with 
time on the x-axis. A third figure displayed SmO2 and heart rate on two y-axes and time on the 





used to display results of the nutritional and training surveys as well as results from VO2 max 
 

































































A total of 6 East Carolina University students (2 males, 4 females) aged 18-23 years 
 
participated in the study. Table 1 shows descriptive characteristics for participants. Overall, 
 
participants were young and healthy, with body composition in the normal range per guidelines 
 
set by the American College of Sports Medicine (ACSM) (Dwyer et al., 2008). 
 
Table 1. Participant Demographics and Anthropometric Measurements 
 Characteristic Mean ± SD Range 
 Age (yrs) 21 ± 2  18-23 
 Height (m) 1.69 ± .12 1.58- 1.88 
 Weight (kg) 69.2 ± 17 50-100 
 Body Fat (%) 18.4 ± 6.3 7.4-25.2 
 Sum of Skinfolds (mm) 104 ± 30 62-134 
 
Table 2 shows training characteristics of participants. Five of the six participants reported 
 
having performed regular endurance training for greater than one year while one subject reported 
 
not having been performing regular endurance style training; however, this subject had a VO2 
 
max similar to the other endurance-trained participants and was permitted to participate in the 
 
study. Four out of the six participants reported an average exercise session lasting between 60- 
 
120 minutes while two participants reported typical exercise duration lasting greater than 120 
 
minutes. Mean exercise intensity reported was 3.6 out of 5. 
Table 2. Training Characteristics 
 Variable Results 
 Participants who engage in endurance training ≥3 days/week for ≥30 5 (83%) 
 minutes each session (n, %)   
 Participants who ran regularly (n, %) 1 (17%) 
 Participants with injury in past year (n, %) 1 (17%) 
 Participants who complete exercise course in school (n, %) 4 (66%) 
 Mean Exercise Frequency (days/week) 5 ± 1 
 Mean Exercise Length (min/session) 90 ± 45 
 Mean Exercise Intensity (scale: 1=light; 5=hard) 3.6 ± 0.8 
 Last 3 results are mean ±SD   
Table 3 shows the results of the dietary questionnaire. Participants reported meeting 
 
USDA guidelines for fruit and vegetable intake with mean consumption of at least 2.5 servings 
 
of fruits and 2.5 servings of vegetables per day (www.choosemyplate.gov). Dairy was reported 
 
to be consumed daily. Poultry was reported to be the most frequently consumed meat. One 
 
participant failed to complete the nutritional and dietary supplement portion of the survey. 
 
Table 3 Dietary Questionnaire 
Question Lowest Value Mean ± SD 
   
Fruit servings per day 2.5 3.1 ± 0.8 
Vegetable servings per day 2.5 3.1 
Grain servings per day 0.2 2.3 ± 1.4 
Dairy servings per day 1.0 1.9 ± 0.8 
Nuts servings per week 0.5 2.1 ± 1.4 
Red meat servings per week 0 0.7 ± 0.4 
Poultry servings per week 2.5 3.7 ± 0.7 
Lunch Meat servings per week 0 1.9 ± 1.9 
Pork servings per week 0 0.9 ± 1.0 
Fish servings per week 0.3 1.5  
Only 5 participants completed questions on dietary intake 
 
Table 4 shows the results of the dietary supplement questionnaire. Results showed an overall 
limited use of dietary supplements among participants. Two participants reported using a 
 
multivitamin daily; two reported using a single vitamin or mineral supplement 2-3 times per 
 
week; and 2 participants reported using a carbohydrate and/or electrolyte supplement 2-3 times 
 
per week. Other supplements that were used at least once a month included protein powder, 
 
amino acids, energy drinks, melatonin and joint formulas. 
 
Table 4: Supplement Use Questionnaire 
Frequency of Use Results 
Multivitamin (n, %) 2 (40%) 
Single vitamin or mineral (n, %) 2 (40%) 
Carbohydrate and/or electrolyte supplement (n, %) 2 (40%) 
Protein Powder (n, %) 1 (20%) 
Amino Acids (n, %) 1 (20%) 
Energy Drinks (n, %) 1 (20%) 
Melatonin (n, %) 2 (40%) 
21  
Joint Formulas (n, %) 1 (20%)  
Only 5 participants completed questions on dietary supplements 
 
Internal Calibration of MOXY Monitors 
 
Table  5  shows  the  range  of  the  MOXY monitors  for each  individual  participant, 
 
establishing  a  minimum  and  maximum  value.  Minimum  values  were  obtained  from  thigh 
 
occlusion and maximum values were obtained from the highest SmO2 values achieved during the 
 
high-intensity intervals. Five out of the six participants achieved SmO2 below 50% in the left and 
 
right quadriceps during calibration. During calibration, four out of the six participants achieved 
 
lower SmO2 during calibration than during interval testing for both the left and right quadriceps. 
 
Participant 004 achieved lower SmO2  in both quadriceps during the interval testing than during 
 
calibration. Participant 005 demonstrated the greatest range during interval testing, with changes 
 
during  interval testing  in  left  and  right  quadriceps  SmO2  of  -78%  and  51%,  respectively. 
 
Participants with the lowest obtained SmO2  during calibration did not demonstrate the greatest 
 
range of SmO2  or reach the highest SmO2  during interval testing, when compared to other 
 
participants. It should be noted that subject 006 produced abnormally high SmO2  values during 
 
the high-intensity intervals. 
 
Table 5. Lowest SmO2 achieved before VO2 Max testing and Highest/Lowest SmO2 During 6 
High-Intensity Intervals  
Subject Lowest Lowest Highest Lowest Lowest Highest 
ID # Calibration Interval Interval Calibration Interval Interval 
 L(%) SmO2 SmO2 R(%) SmO2 SmO2 
  L(%) L(%)  R(%) R(%) 
001 45 64 99 28 63 84 
002 28 30 73 41 45 75 
003 30 68 92 41 50 90 
004 39 27 61 85 55 87 
005 55 21 99 39 45 96 
006 36 92 97  96 99  
Lowest right quadriceps SmO2 during calibration was unavailable for participant 006  




VO2 Max Testing 
Tables 6 shows the results obtained from the VO2 max test, including participant’s VO2 
 
max, maximum heart rate, blood lactate levels before and after the VO2 max test and maximum 
 
wattage. All  subjects achieved a VO2 max  above the inclusion  criteria minimum  of  30 
 
ml/kg/min,  supporting  their  status  as  endurance-trained  with  all  participants  scoring  in  the 
 
categories of fair, good, excellent and superior (Heyward, 1998). Post VO2 max BL levels 
 
reflected maximum effort as defined as ≥7 mmol/l for participants 001, 002, 004, 005 and ≥9 
 
mmol/l for participants 003 and 006 based on gender and age (Evardsen, 2014). 
 
Table 6 VO2 Max Testing 
Subject VO2 Max Max BL BL SmO2 SmO2 SmO2 Max 
ID # (ml/kg/min) HR Before After D (%) L (%) R (%) Wattage 
  (bpm) VO2 VO2    (W) 
   Test Test     
   (mmol/l) (mmol/l)     
001 38.7 202 1.1 12 67 27 44 170 
002 33.2 188 1.3 7.7 56 26 39 170 
003 51.8 180 8.1 12.9 64 63 47 305 
004 37.7 194 4.0 12.9 37 30 63 110 
005 52.9 194 2.3 13.2 77 52 41 290 
006 42.8 182 3.4 19.6 83 96 99 305  
SmO2 D= deltoid MOXY monitor SmO2 L= left quadriceps MOXY monitor SmO2 R= right 
quadriceps MOXY monitor  
SmO2 data taken at time VO2 max was achieved 
Max wattage reflects the wattage of the last fully completed 60-second interval 
 
High Intensity Intervals 
 
Three of the six participants were selected for the graphical illustrations and tables below. 
 
Two females and one male were selected (002, 003, 004) for analysis because their SmO2 was 
 
measurable throughout testing and blood lactate samples were adequately obtained for 
 
participant 002. Participant 003 had the highest maximum wattage during the VO2 max test and 
 
one of the highest VO2 max scores. Participant 003 was an ECU tennis player who reported 
 




relationships and patterns seen among the variables measured including SmO2 and VO2, SmO2 
and HR and SmO2 and BL. 
 
SmO2 and THb During Six High Intensity Intervals 
 
Figures 1 a, b and c illustrate the pattern of SmO2 and THb during the six high-intensity 
intervals for participants 002, 003 and 004. Participants showed clear decreases in SmO2 during 
each of the 6 intervals. Notably, troughs in SmO2 were often seen to occur about 10 seconds 
after the end of the intervals. Progression through the 6 intervals revealed an overall increase in 
SmO2 for participant 002 while participant 004 had an increase in the right quadriceps and a 
decrease in the left quadriceps as the intervals progressed. Left quadriceps SmO2 decreased 
during each interval in all three participants but differed in the progressive pattern. SmO2 in the 
left quadriceps for participant 003 remained relatively stable, ranging between 87%-90%. 
Participant 004 showed an overall decrease in the left leg, falling from 54-35%. Right quadriceps 
SmO2 remained relatively stable in participant 003. THb in participants 002 and 004 remained 
stable with little overall change. Participant 003 demonstrated decreases in THb during each of 
the 6 intervals. Participant 002 showed a decrease in deltoid SmO2 during each interval but 
remained relatively stable overall, returning to prior values between intervals. Participant 003 
also showed a decrease in deltoid SmO2 during intervals but with a slight overall increase, rising 


















Figure 1a. Participant #002 SmO2 (%) of the left and right quadriceps and THb( g/dl) 
across time 
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  SmO2 S (%)  SmO2 L (%)   SmO2 R (%)   THb L (g/dl)   THb R (g/dl)  
Interval 1- 1:30-2:00 min Interval 2- 3:30-4:00 min Interval 3- 5:30-6:00 min      
Interval 4- 7:30-8:00 min Interval 5- 9:30-10:00 min Interval 6- 11:30-12:00 min     
SmO2 D= Deltoid MOXY monitor SmO2 L= Left Quadriceps MOXY monitor SmO2 R= Right  
Quadriceps MOXY monitor                       
 
Table 7a SmO2 and total hemoglobin (THb) at start and end of intervals 
 Subject #002 Deltoid SmO2 L Quad SmO2 R Quad SmO2 L Quad THb R Quad THb 
 (%) (%) (%) (g/dl) (g/dl) 
 Start/End Start/End Start/End Start/End Start/End 
       
 Interval 1 71/66 37/34 52/46 11.6/11.6 11.6/11.6 
 Interval 2 76/67 41/31 58/49 11.6/11.7 11.6/11.6 
 Interval 3 78/66 45/33 65/51 11.6/11.6 11.6/11.6 
 Interval 4 77/69 53/39 70/59 11.6/11.6 11.6/11.5 
 Interval 5 75/67 64/51 74/62 11.5/11.4 11.6/11.5 
 Interval 6 75/62 72/59 75/64 11.5/11.3 11.6/11.4 
 Avg Change -9.2% -10.8% -10.5% -.05 mg/dl -.04 mg/dl 















Figure 1b. Participant #003 SmO2 (%) of the left and right quadriceps and THb(g/dl) 
across time 
 
         SmO2 and Total Hemoglobin          
 100                           13  
 90                           12.5  
(%
) 









                          
                          11.5 
60 
                          
                          
11 2
                           





                          
                          
10.5 40                           
 30                           10  
                           
9.5 
 
 20                            


























































































































  SmO2 S (%)   SmO2 L (%)   SmO2 R (%)   THb L (g/dl)   THb R (g/dl)  
 
 
Table 7b SmO2 and Total Hemoglobin (THb) at Start and End of Intervals 
 Subject Deltoid  SmO2 LeftQuad Right Quad Left Quad THb Right Quad 
 #003 (%) SmO2 (%) SmO2 (%) (mg/dl) THb  
 Start/End Start/End Start/End  Start/End Start/End  
 Interval 1 69/50 90/79 83/60  12.1/ 11.5 12.0 / 11.7  
 Interval 2 72/57 88/71 82/55  12.0/ 11.5 12.1/ 11.7  
 Interval 3 74/59 87/72 83/56  12.0/ 11.4 12.1/11.7  
 Interval 4 77/63 89/74 86/52  12.1/11.5 12.3/11.7  
 Interval 5 65/66 89/70 86/55  12.2/11.5 12.3/11.8  
 Interval 6 76/65 88/68 84/56  12.1/11.5 12.2/11.8  
 Avg Change -12.2% -16.2% -28.3%  -.61 mg/dl -.44 mg/dl  
 Per Interval        
 
Figure 1c. Participant #004 SmO2 (%) of the left and right quadriceps and THb( g/dl) across 
time 
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   SmO2 S (%)  SmO2 L (%)  SmO2 R (%)   THb L (g/dl)   Thb R (g/dl)  
              26                 
 
Table 7c SmO2 and Total Hemoglobin (THb) at Start and End of Interval 
 Subject Deltoid Left   Quad Right   Quad Left Quad Right Quad THb 
 #004 SmO2 (%) SmO2 (%) SmO2 (%) THb (mg/dl) (mg/dl) 
 Start/End Start/End Start/End Start/End Start/End 
       
 Interval 1 56/53 54/37 71/63 11.6/11.6 11.7/11.7 
 Interval 2 48/48 46/34 69/58 11.7/11.8 11.73/11.7 
 Interval 3 48/43 47/32 77/57 11.7/11.7 11.8/11.6 
 Interval 4 41/49 40/32 80/68 11.8/11.7 11.8/11.5 
 Interval 5 44/42 49/27 85/80 11.6/11.7 12.0/11.7 
 Interval 6 52/33 35/28 86/78 11.6/11.6 11.9/11.5 
 Avg Change -3.5% -13.5% -10.7% +.03 mg/dl -.22 mg/dl 
 Per Interval       
 
Progressive Changes in Measured Variables During the Six High-Intensity Intervals 
 
Tables 8a, b and c show the patterns seen among the measured variables. The BL values 
 
≥7mmol for  females and ≥9mmol/l for men demonstrate the maximal effort exerted by the 
 
participants. BL was shown to increase in participant 002 through the first 3 intervals, followed 
 
by slight decrease in the last 3 intervals. Only 2 BL measurements were obtained for participants 
 
003 and 004, both showing an increase. HR also increased through intervals 1-6 showing an 
 
increase in effort and fatigue. VO2 reached between 86.3 and 92.6% VO2 max for participants, 
 
also  demonstrating  effort.  SmO2  in the  left  quadriceps  was  shown to  slightly increase  for 
 
participant  002  while  it  decreased  for  participants  003  and  004.  Right  quadriceps  SmO2 
 
remained stable for participant 002, decreased in participant 003 and increased in participant 
 
004. Deltoid SmO2 increased for participants 002 and 003 while decreasing for participant 004, 
 
suggesting there may have been upper body movement during the intervals. Participant 002 
 
demonstrated exceptionally high BL levels, peaking at 19.8mmol/l at the end of interval 3. An 
 
increase over the first 3 intervals was seen in this participant followed by a slight decrease from 
 










Table 8a. Participant #002. Interval Ending Measurements 
 Interval # SmO2 SmO2 SmO2 Blood Heart VO2  %    VO2 
 D(%) L(%) R(%) Lactate Rate (ml/kg/min) Max 
    (mmol/l) (bpm)     
 1 34 46 66 9.2 169 28.8  86.7  
 2 31 49 67 16.8 175 28.4  85.5  
 3 33 51 66 19.8 176 25.8  77.7  
 4 39 59 69 18.6 179 28.7  86.4  
 5 51 62 67 15.1 179 27.6  83.1  
 6 59 64 62 14.5 182 29.1  87.7  
 Table 8b. Participant #003. Interval Ending Measurements     
 Interval SmO2 SmO2 SmO2 Blood Heart VO2 % VO2 
 # D(%) L(%) R(%) Lactate Rate (ml/kg/min) Max 
    (mmol/l) (bpm)     
 1 50 79 60  164 34.2 66   
 2 57 71 55 11 168 43.5 84   
 3 59 72 56  170 44.7 86.3  
 4 63 74 52  167 39.8 76.8  
 5 66 70 55  171 42.2 81.5  
 6 65 68 56 16.1 174 43.5 84   
 Table 8c. Participant #004. Interval Ending Measurements     
 Interval SmO2 SmO2 SmO2 Blood Heart VO2 % VO2 
 # D(%) L(%) R(%) Lactate Rate (ml/kg/min) Max 
    (mmol/l) (bpm)     
 1 50 36 62 8.3 180 26.2 69.5  
 2 44 35 59 11.8 188 30.8 81.7  
 3 41 32 55  190 33.1 87.8  
 4 46 30 67  190 34.9 92.6  
 5 36 28 80  187 30.9 82.0  
 6 35 26 76  190 34.9 92.6   
Blank spaces indicate unavailable data (lost MOXY monitor reading or blood lactate reading 
error)  











Relationship between SmO2 and VO2 During High-Intensity Intervals 
 
Figures 2 a, b and c illustrate the inverse relationship seen among SmO2 and VO2 during 
each of the 6 intervals. Both VO2 and SmO2 were plotted every 20 seconds to allow comparison, 
as the VO2 value was taken by the metabolic cart every 20 seconds during testing. A decrease in 
SmO2 of the left and right quadriceps was consistently seen during each interval among the three 
participants illustrated in the graphs. Simultaneously, VO2 was shown to increase during each of 
the six intervals. Interval progression showed peak VO2 during interval testing occurred at the 
end of interval 6 for participants 002 and 004 and interval 3 for participant 003. Participant 002 
demonstrated an overall increase in SmO2 in both quadriceps as the intervals progressed, while 
VO2 increased steadily. Peak VO2 during the intervals did not consistently occur at the end of 
the intervals. Participant 002 saw several spikes in VO2 between intervals, often occurring about 
40 seconds after the end of the interval. For example, spikes are seen at 2:40, 4:40, 6:20, 8:40, 
10:40 and 12:40. A similar pattern was seen in evaluating participant 003, with peaks in VO2 
often occurring at 20 or 40 seconds after the end of the interval. 
 
Figure 2a. Participant 002. SmO2 (%) of the left and right quadriceps and VO2 
(ml/kg/min) across time  
SmO2 and VO2 
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Interval 1- 1:30-2:00 min Interval 2- 3:30-4:00 min Interval 3- 5:30-6:00 min 
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Interval 4- 7:30-8:00 min Interval 5- 9:30-10:00 min Interval 6- 11:30-12:00 min 
 
 
Figure 2b. Participant #003 SmO2 (%) of the Left and Right Quadriceps and VO2 (ml/kg/min) 
across time 
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Figure 2c. Participant #004. SmO2 (%) of the left and right quadriceps and VO2 (ml/kg/min) 
across time 
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Relationship between SmO2 and HR During High-Intensity Intervals 
 
Figures 3 a, b and c illustrate the inverse relationship observed between SmO2 and heart 
rate among the three participants. During each interval, heart rate consistently increased while 
SmO2 in the left and right quadriceps decreased. As the intervals progressed, an increase in 
resting HR between intervals was seen in participants 002 and 003 while participant 004 showed 
a smaller range between 181-192 bpm with obvious decreases seen during the intervals. Peak HR 
was shown to consistently occur at the end of each of the intervals, with most occurring right at 
the end of the 30-seconds. However, SmO2 troughs were shown to consistently occur about 10 
seconds after the end of the interval, showing peak HR and SmO2 troughs to not be exactly 
aligned. 
 
Figure 3a. Participant #002. SmO2 (%) of the left and right quadriceps and heart rate (bpm) 
across time 
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        SmO2 L (%)  SmO2 R (%)  HR (BPM)       
Interval 1- 1:30-2:00 min Interval 2- 3:30-4:00 min Interval 3- 5:30-6:00 min Interval 4- 7:30- 













Figure 3b. Participant #003. SmO2 (%) of the left and right quadriceps and heart rate 
(bpm) across time 
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Figure 3c. Participant #004. SmO2 (%) of the left and right quadriceps and heart rate (bpm) 
across time 
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Relationship between SmO2 and Blood Lactate 
 
Tables 9 a, b, and c present the changes seen in SmO2 of the right and left quadriceps as 
well as the blood lactate taken at the end of each of the 6 high-intensity intervals. Increases were 
seen in BL as both right and left quadriceps SmO2 increased and decreased. Peak BL did not 






Table 9a Participant 002. SmO2 (%) of the left and right quadriceps and blood lactate (mmol/l) 
taken at the end of each interval  
 Left  Quad SmO2    Right  Quad SmO2    Blood Lactate 
 (%) (%) (mmol/l) 
 Interval 1 34 46 9.2 
 Interval 2 31 49 16.8 
 Interval 3 33 51 19.8 
 Interval 4 39 59 18.6 
 Interval 5 51 62 15.1 
 Interval 6 59 64 14.5 
 
 
Table 9b Participant 003. SmO2 (%) of the left and right quadriceps and blood lactate (mmol/l) 
taken at the end of each interval  
 Left Quad SmO2 (%) Right Quad  SmO2   Blood Lactate 
  (%) (mmol/l) 
 Interval 1 79 60  
 Interval 2 71 55 11 
 Interval 3 72 56  
 Interval 4 74 52  
 Interval 5 70 55  
 Interval 6 68 56 16.1 
 
 
Table 9c Participant 004. SmO2 (%) of the left and right quadriceps and blood lactate (mmol/l) 
taken at the end of each interval  
 Left  Quad Right   Quad Blood Lactate 
 SmO2 (%) SmO2 (%) (mmol/l) 
 Interval 1 37 63 8.3 
 Interval 2 34 58 11.8 
 Interval 3 32 57  
 Interval 4 32 68  
 Interval 5 27 80  
 Interval 6 28 78  

















Chapter 5: Discussion 
 
Improving the aerobic capacity of an athlete requires improvements in the ability to 
monitor and assess physiological adaptations created in response to training programs. Exercise 
tools, such as monitors used to measure heart rate, metabolic carts to measure the volume of 
oxygen consumed (VO2) and portable meters to measure blood lactate are just some of the ways 
these adaptations are measured and evaluated. Over the past few decades, near infrared 
spectroscopy (NIRS) has emerged as a technology that may serve as a useful exercise tool to 
monitor and evaluate muscle oxygenation patterns within working muscles of the athlete. With 
the emergence and increased accessibility of more portable and wireless NIRS instruments, the 
need for assessing the applicability and usefulness for obtaining muscle oxygen has increased. 
This study sought to identify if the MOXY monitor output followed patterns of established 
physiological factors, including heart rate, VO2 and lactic acid. The purpose of this study was to 
assess the output provided by the MOXY monitor, muscle oxygen saturation (SmO2), to 
compare with expected physiological changes. Eg. A decrease in SmO2 as VO2, heart rate, and 
blood lactate increase. Our hypothesis was that SmO2 would decrease during the 30-second 
intervals as VO2, heart rate and blood lactate increased and that troughs in SmO2 would coincide 
with peaks in the other variables. 
 
This study relied on comparing observed measurements to expected physiological 
patterns. These patterns are centered around known physiological responses to exercise that have 
been well-studied in literature. Anaerobic exercise, done at higher intensities, creates a higher 
respiratory rate as the demand for oxygen increases. This increased need for oxygen causes an 
increase in heart rate to keep up with blood and oxygen delivery, thereby also creating an 
increase in the volume of oxygen consumed (VO2). As the body struggles to maintain adequate 
 
oxygen delivery, the body begins to accumulate blood lactate as a product of anaerobic 
metabolism. This point at which blood lactate begins to increase exponentially is referred to as 
the lactate threshold (McArdle et al., 2015). As less oxygen becomes available during these high 
intensities and heart rate, VO2 and blood lactate increase, a decrease in muscle oxygen saturation 
in working muscles would be expected as oxygen is less available. Therefore, an inverse 
relationship between SmO2 and heart rate, VO2 and blood lactate would be in agreement with 
physiological expectations. 
 
By testing six participants during 6 high-intensity intervals on a cycle ergometer, we 
found an inverse relationship among SmO2 when plotted against VO2 and heart rate. As SmO2 
decreased during each of the 30-second intervals, both VO2 and heart rate increased. A notable 
finding was that many intervals demonstrated a 10-second delay among SmO2 troughs. Rather 
than reaching a trough at the end of the 30-seconds, lowest SmO2 occurred around 10-seconds 
after the 30-second interval ended. This pattern was observed in several intervals for the 
participants but was not seen in all intervals. The patterns illustrated by SmO2 supports our 
hypothesis that MOXY output would provide SmO2 values that would decrease during high-
intensity intervals, as a high-intensity anaerobic environment has been shown to decrease muscle 
oxygenation in similar studies using other muscle oxygen saturation monitors. 
 
Hypothesis 1: BL will illustrate an inverse relationship to SmO2 by increasing with each 
interval as SmO2 will decrease as the intervals progress from interval 1 to interval 6. 
 
The support of this hypothesis was not able to be determined, due to clear patterns not 
being able to be evaluated as only two participants out of six had all 6 BL samples successfully 
obtained. These participants demonstrated similar patterns, increasing during the first 3-4 




similar pattern of increasing through the beginning intervals before decreasing, despite only 
having 5 BL values obtained. Both HR and VO2 were shown to increase during the last 2-3 
intervals for these participants, demonstrating sufficient effort and intensity was provided by the 
participants, thereby disproving the assumption that the participants simply decreased their 
efforts. Blood lactate proved to be difficult to measure, as the lactate meter displayed an error 
message for twelve out of the total thirty-six readings attempted during the high-intensity 
intervals. 
 
Hypothesis 2: SmO2 will illustrate an inverse relationship to HR by decreasing during 
the intervals while HR increases and peak HR values will coincide with troughs in SmO2. 
 
The hypothesis was supported as the inverse relationship was observed in the present 
study, with SmO2 decreasing and HR increasing during the intervals for all 6 participants. A 
delay of about 10 seconds observed among some SmO2 troughs, compared to peak HR which 
consistently occurred at the end of the 30-second intervals. It is unclear as to whether this delay 
in SmO2 was due to a physiological delay in muscle deoxygenation or a delay in the MOXY 
monitor’s ability to measure live values. Overall the hypothesis was supported that decreases in 
SmO2 were inversely related to increases in HR. 
 
Hypothesis 3: SmO2 will illustrate an inverse relationship with VO2 by decreasing 
during the 30-second intervals as VO2 increases. Troughs in SmO2 will coincide with VO2 peak 
values. 
 
The hypothesis was supported in the present study as SmO2 was shown to decrease 
during the intervals and VO2 was shown to increase. The degree to which the two variables 
changed did not seem to be related, as SmO2 decreased to varying degrees and did not 




occur around 20 to 40 seconds after the end of the interval when SmO2 had begun increase. 
Thus, the hypothesis that peaks in VO2 and troughs in SmO2 would coincide was not supported. 
It should be noted that the metabolic cart was programmed to measure VO2 every 20 seconds, 
thereby limiting the available data to show a relationship among the two variables. SmO2 values 
were plotted every 20-seconds as well so as to allow comparisons between the two variables. 
Overall, the hypothesis was partially supported as SmO2 showed clear decreases during the 
intervals as VO2 increased, despite peaks and troughs failing to coincide. 
 
Comparison of MOXY Monitor Data to other NIRS monitors 
 
As NIRS evolves into a more commonly used tool for monitoring exercise adaptations it 
is imperative that supporting research continues to provide relevant information that positions 
muscle oxygenation in its appropriate place among exercise tools. While much research has been 
done in validating NIRS as an accurate way to measure muscle oxygenation, less research is 
available in assessing the more commercial NIRS devices, such as MOXY. To our knowledge, 
no studies have been done examining the output provided by the MOXY monitors compared to 
more established variables like VO2, HR and BL. With differing numbers of light sources and 
detectors, as well as algorithms and calculations, it is wrong to assume all new NIRS instruments 
will provide useful data. This study sought to address this gap in MOXY literature by assessing 
the data provided by the MOXY monitor compared to other parameters, including HR, VO2 and 
BL. 
 
The major findings in the present study were the inverse relationships observed between 
SmO2 and heart rate and SmO2 and VO2, which fall in line with expected physiological patterns 
based on anaerobic metabolism. This relationship suggests SmO2 output provided by the MOXY 




significant increases in VO2 with repeated 6-second sprints on a cycle ergometer that 
corresponded to increases in muscle deoxygenation; thereby supporting an inverse relationship 
between muscle oxygenation and VO2. Racinais used a validated non-portable NIRO 300 
(Hamamatsu, Japan) NIRS instrument to assess muscle oxygenation. A pattern seen among some 
of our participants was an increase in muscle oxygenation as the intervals progressed. Both HR 
and VO2 remained elevated, even peaking in some participants, during the final 3 intervals, 
suggesting that adequate effort was given by the participants. In the ten 6-second sprints 
conducted by Racinais, muscle oxygenation decreased with the repeated sprints; however, 30-
second recovery periods were used between sprints. It is likely that the 90-second rest periods 
used between the intervals in the present study allowed participants to enter a recovery period, in 
which previous research has observed increases in SmO2. Studies by Bellardinelli et al. (1995) 
and Bhambhani et al. (1997) both observed rapid increases in muscle oxygenation during the 1-2 
minutes following incremental exercise. This suggests that the 90-second rest periods were 
sufficient as to allow recovery and led to the progressive increase in SmO2 seen among some of 
the participants. This finding in the present study is of interest, as the recovery in muscle 
oxygenation may be an area of future significance. Studies by Chance et al. (1992) and Ding et 
al. (2001) found that well trained athletes exhibited faster recovery in muscle deoxygenation than 
untrained participants. It may be a focus of later studies to examine the use of MOXY as a means 
of assessing reoxygenation patterns as a response to various training programs. Similar to heart 
rate variability, SmO2 recovery between bouts of exercise may be an area worth further 
exploration. 
 
The present study had similar findings to previous studies using portable NIRS. A 2013 




university rugby players during repeated shuttle sprints using a wireless PortaMon monitor while 
heart rate and blood lactate were also measured. Mean BL taken immediately after the shuttles 
tests was 14.3 mmol/l and mean heart rate was 182bpm. The present study observed a post 
interval testing BL mean of 13.4mmol/l (5 participants had interval ending BL obtained) and a 
mean HR of 182.0 bpm at the end of the intervals. Muscle oxygenation in the study by Jones 
decreased by a mean of 24.4% during each interval whereas the present study saw a mean 
decrease in SmO2 of 13.2%. Findings in VO2, HR and muscle oxygenation from the present 
study were similar to findings obtained by Jones, with some difference seen in the degree of 
deoxgenation using the different protocols. This suggests that VO2 and HR increase while 
muscle oxygenation decreases as measured by the PortaMon NIRS monitor. 
 
Although the current study was unable to determine a relationship between blood lactate 
and muscle oxygenation, other studies have supported such a relationship. Miura et al. (2000) 
examined muscle oxygenation using NIRS and blood lactate during five, 6-minute cycling 
intervals. Blood lactate was measured at the end of each interval using a fingertip method similar 
to the present study. A correlation was observed between the percentage of oxygen saturation 
and blood lactate accumulation, suggesting that monitoring muscle oxygenation using NIRS may 
be a preferred method over blood collection as it is less invasive. Many other studies using NIRS 
have also supported the relationship between muscle oxygenation and blood lactate (Grassi, 1999 
& Bellotti, 2013). 
 
The findings obtained in the present study demonstrate a pattern of continuing decreases 
in SmO2 during each of the 30-second intervals accompanied by increases in HR and VO2. With 
these observed changes, troughs in SmO2 and peaks in HR and VO2 did not always coincide. 




collection prevented conclusions from being made about patterns in BL; however, the BL values 




The site with which the MOXY monitors were placed likely had the MOXY monitors 
assessing the rectus femoris muscles. Previous research examining cycling exercise has 
identified the vastus lateralis as one of the more active muscles during cycling exercise and is 
often chosen as the site measured using NIRS technology during cycling exercise (Miyashita, 
M., 1981). This limits the present study in being compared to other literature as the exact muscle 
being measured may differ. Muscle oxygenation of the rectus femoris and the vastus lateralis 
muscles should be similar as the muscular physiology should remain constant despite differences 
in degree of use during cycling exercise. 
 
The calibration protocol used in the present study was adopted by the recommendations 
of Terence Ryan, an expert in NIRS technology. In his own studies, an occlusion protocol was 
used with a blood pressure cuff to occlude the testing muscle so as to achieve a minimal value 
for comparison, thereby calibrating the NIRS instrument. This procedure was limited in the 
present study by the availability of an appropriate cuff capable of occluding above the thigh. 
Additionally, the protocol included increasing pressure as tolerated by the participant and 
waiting until SmO2 values plateaued for greater than 30-seconds. One participant, 006, did 
become uncomfortable during this testing procedure and chose to stop the calibration. The cuff 
also came undone numerous times, causing the procedure to be restarted and possibly 
influencing the results. The application of this protocol became very difficult and provided little 






using MOXY may wish to use a more appropriate blood pressure cuff capable of occluding the 
quadriceps muscles or test a smaller muscle easily occluded using a standard sized cuff. 
 
As previously mentioned, BL proved to be very difficult to obtain. Twelve BL 
measurements were unavailable as the lactate meter displayed an error message upon applying 
the blood samples. Possible reasons may have included sweat interference, calloused hands or 
application error by the researcher applying the blood sample to the meter. It was noted that 
participant 003 had very calloused hands, causing inadequate amounts of blood to be obtained. 
The missed samples were important in having the ability to observe patterns in BL throughout 
the intervals. The issue with obtaining BL values resulted in only 2 participants having a 
complete BL panel and two participants having only 2 values. Further studies may want to 
explore other means for obtaining BL or improved protocols making BL collection easier. 
 
The computer program used to set the cycle ergometer to adjust wattage during interval 
testing automatically, proved to take longer than expected to reach ideal wattage. The high-
intensity intervals were completed at 125% of maximum wattage achieved during the VO2 max 
test. For participants with a high maximum wattage (2 participants had a maximum wattage of 
305W) it took between 10-15 seconds for the cycle to reach the desired value. This means the 
participants may have only cycled for about 15 seconds at the desired wattage which may have 
limited the decreases in SmO2 and increases in HR/VO2/BL. Future studies may wish to adjust 
the cycler ergometer protocol to account for the time needed to reach desired wattage. 
 
Another important limitation in this study was the apparent loss in signal obtained by the 
MOXY monitor, evident by a reading of 0% in the SmO2 values produced by the Peripdal 
program. This was seen among participants 001, 005 and 006 and led to 002,003 and 003 being 




possible suggestions include a lost connection or inappropriate taping of the monitor allowing 
ambient light to interfere with the NIRS signal. It is important for future researchers using 
 
MOXY monitors to ensure the monitors are firmly taped to the participant’s skin as shifting of 
the monitor during exercise may lead to errors in the readings. Further research will be needed to 
explore this concern in MOXY output. 
 
In addition to the 0% readings, abnormally high SmO2 values were seen among 
participant 006. SmO2 values remained well above 90% during all intervals which is highly 
unlikely given the high HR, VO2 and BL values, demonstrating adequate effort was provided by 
the participant. These values are skeptical as they do not agree with the other participants in the 
present study. Further research is needed to explore abnormally high SmO2 values provided by 
the MOXY monitor as they do not follow observed values in otter participants. 
 
THb was predicted to remain consistent throughout testing and was supported in the 
illustrations provided by participants 002 and 004. Participant 003 demonstrated decreases in 
THb with each of the six intervals, which is contrary to expectations as THb would be predicted 
to remain consistent. The reason for this finding is unknown and warrants further exploration. 
 
Participants were instructed to not exercise or eat in the hours before testing. However, 
participant 003 admitted to having completed an upper body workout on the morning of testing 
after testing had been completed. This may explain the above normal BL reading of 8.1mmol/l 
prior to the VO2 max test. Findings and values obtained on participant 003 may be have been 




The benefits of being able to use a wireless NIRS instrument to monitor muscle 




threshold, assess oxidative metabolism and estimate blood lactate production without the use of 
blood samples (Bhambhani et al., 2004; Ding et al., 2001; Miura et al., 2000). Wireless NIRS 
technology allows researchers to further explore the ways in which muscle oxygenation changes 
with differing exercise modalities and in various environments. Portable NIRS technology allows 
researchers the ability to monitor improvements in oxygen utilization in a variety of settings to 
develop an optimal training program for all types of athletes. Some research has suggested that 
the ability to recover between high-intensity intervals, referred to as reoxygenation may be more 
indicative of the aerobic training state of the athletes and demonstrate a greater oxygen 
utilization capacity (Ding 2001). This would prove to be valuable information for anyone 
looking to improve aerobic fitness, including endurance athletes, athletes performing repeated 
sprints and even military personnel. Military training places a major emphasis on aerobic fitness 
testing, especially running, which when done excessively has been shown to increase training 
injuries (Knapik, 2009). As the Physical Readiness Program (PRT) implements new training 
programs incorporating varying exercise to increase physical fitness (Knapik, 2009), it may be 
worthwhile for the military to explore using portable NIRS monitors like MOXY to monitor 




NIRS monitors have made major leaps in usefulness as they have become more mobile, 
easier to use and less expensive. As more monitors touting superiority in measuring precision 
become available in the commercial market, the need for validation and assessment will remain a 
priority. Future studies may wish to compare the MOXY monitor to more clinically established 
monitors for validation. As the MOXY monitor is marketed as a tool to monitor and guide 




muscle oxygen utilization from various types of training. For example, observing overall 
increases in SmO2 with a given amount of work after completion of a specific training program. 
Further studies may also wish to evaluate more anaerobic styles of training on changes in muscle 
oxygenation including sprinting programs and resistance training. 
 
As aerobic exercise is based on oxidative metabolism and reliant on mitochondrial 
capacity, using MOXY to monitor mitochondrial biogenesis may also be worthy of exploration. 
Previous work has found NIRS devices capable of accurately and reliably measuring 
mitochondrial function after exercise (Ryan et al. 2014). This certainly warrants further studies 
as mitochondria is a focal point for endurance monitoring. 
 
As heart rate evolved into a more popular exercise tool, the attention shifted from 
monitoring heart rate peaks and troughs during exercise to monitoring heart rate variability. The 
same focus has been suggested for muscle oxygenation. Rather than focusing on the peaks and 
falls of muscle oxygenation, it may be more useful to focus on the speed of reoxygenation from 
repeated bouts of exercise. This area of research warrants further exploration and may be a focus 
for future studies using the MOXY monitor. 
 
With the increase in popularity of wearable technologies like the Fitbit and Garmin 
watches, changes in the way NIRS is used may be on the horizon. A review by Hamoaka et al. 
(2011) suggests wearable NIRS technology in the form of clothing may be next for NIRS. A 
NIRS device embedded into the clothing with the ability to use portable solar energy sources 
may be the next step for a company like MOXY. 
 
Conclusion and Summary 
 
The major findings of the present study were the inverse relationships observed between 




physiological expectations. SmO2 was shown to decrease during the high-intensity intervals 
while VO2 and HR increased. Troughs in SmO2 were seen at the end of the intervals, with 
several occurring about 10 seconds after the interval. HR consistently peaked at the end of the 
interval while VO2 increased at the end of the interval and often achieved peak values at around 
40 seconds after the interval. A pattern among BL was not able to be determined as only 2 
participants had all 6 BL samples collected. These two participants, as well as another with 5 
collected samples, demonstrated a progressive increase in BL from intervals 1-3 followed by a 
slight decrease in the last 2-3 intervals. As exercise intensity increases and reaches an anaerobic 
state, it would be physiologically expected for heart rate, VO2 and blood lactate to increase 
while muscle oxygen decreases. It was hypothesized that the MOXY monitors would provide 
data supporting these assumptions, suggesting that MOXY is a reliable tool for exercise. In 
evaluating 6 East Carolina University students during six 30-second intervals on a cycle 
ergometer, inverse relationships between SmO2 and heart rate and SmO2 and VO2 were 
observed among all participants. The patterns identified illustrate the ability for the MOXY 
monitors to observe changes in SmO2 during high-intensity cycling intervals that coincide with 
physiological expectations. This study suggests MOXY may be a useful tool that can be used to 
monitor muscle oxygen utilization in a more noninvasive manner that may simultaneously reflect 
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If you do not want to take part in the study, tell the person explaining the research that you 
do not want to sign this form. 
 
You do not have to take part in this research study. That decision is yours and it is okay to decide 
not to volunteer. 
 
Why is this research being done?  
The purpose of this research is to evaluate a new technology called MOXY as a potential training tool 
for the military. You are being invited to take part in this research because you are a healthy endurance 
 
trained ECU student and/or a ROTC cadet who closely mimics the physical training of the military. The 
decision to take part in this research is yours to make. By doing this research, we hope to learn more 
about muscle oxygen patterns during exercise and whether or not MOXY can be used as a training tool. 
 
Why am I being invited to take part in this research?  
You are being invited to take part in this research because you are a healthy endurance trained ECU 
student and/or in the ECU ROTC program and between the ages of 18 and 30 years. You are a healthy 
and physically active individual who does aerobic exercise for at least 30 minutes, 3 times per week over 
the previous 6 months. If you volunteer to take part in this study, you will be one of about 20 people to 
do so. 
 
Are there reasons I should not take part in this research? 
I understand I should not volunteer for this research study if I am not at least 18 years of age or if I 
am over the age of 30. Also, I should not participate if I am not healthy enough to cycle on a bike at 
a high intensity for more than 30 minutes. I understand that if I don’t reach at least 40ml/kg/min 
on the VO2 max test, I will not continue the study to the high intensity intervals. I should not 
participate if I have had a musculoskeletal injury within the past 3 months, have a history of 
cardiovascular disease or bleeding disorders. 
 
What other choices do I have if I do not take part in this research?  
You have the choice of not taking part in this research study. 
 
Where is the research going to take place and how long will it last?  
The research will be conducted in the Biosafety Level 2 Certified (BSL2) Human Performance Lab 
(Room 363) in the Ward sports medicine building at East Carolina University. You will need to 
come to room 363 Ward Sports Medicine Building located on the 3rd floor just one time during 
the study. The total amount of time you will be asked to volunteer for this study is 90 minutes. 
 
What will I be asked to do?  
The following procedures will be done strictly for research purposes.  
You will be asked to do the following:  
After completing this consent form, you will complete a food and training survey, which 
will include questions regarding previous training and eating habits.  
Once all forms have been completed, the researcher will measure your height, weight, 
and body fat. Body fat will be calculated using a 7-site skin fold in which 7 anatomical 
landmarks will be measured on your upper and lower body.  
A MOXY monitor will be taped to the front of both of your quadriceps as well as one 
taped to your left shoulder. A blood pressure cuff will be placed around your leg and 
pressure will be applied to attempt to have the MOXY monitor read 0%. This is to 
calibrate the monitor and will be stopped when the monitor reaches 0% or the reading 
remains the same for 10 seconds, indicating it has plateaued.  
All testing will be conducted on the same day.  
Before VO2 max testing begins, a needle-size drop of blood will be taken using a blood 
lactate analyzer to measure a baseline blood lactate level. This will provide a baseline for 





takes just 13 seconds to display the blood lactate reading. The device and procedure is 
very similar to a finger prick used for blood glucose testing.  
You will perform a VO2 max test in which you will cycle on a bike for approximately 8-
12 minutes. The resistance and difficulty of pedaling will increase every minute until you 
can no longer maintain 70 rotations per minute (rpm). The test will then be completed.  
o A VO2 max test is a way to assess aerobic fitness level. It is a physically progressive 
testing protocol that increases in intensity with duration until you cannot maintain 
70 rpms on the bike. This enables researchers to quantify your endurance 
capacity. Data from this evaluation will be used to determine intensity during the 
high intensity intervals and provide the 40ml/kg/min cutoff for participants.  
Headgear will be worn that will include a headpiece and mouthpiece that may 
be uncomfortable at first.  
A nosepiece will also be worn to close off nose breathing.  
Your feet will be taped to the bike pedals to ensure the pedal straps do not come 
undone while cycling at high intensities.  
VO2 max testing protocol:  
o You will begin pedaling at a rate of 70 rpm and 50 watts (W)  
o After each minute, the watts will be increased by intervals of 15. The watts will 
be increased as follows: 50W, 65W, 80W, 95W, 110W, 125W, 140W, 155W,  
170W, 205W, 220W, 235W, 250W etc.  
o You will continue this pattern until you can no longer maintain 70 rpms. Once the 
rpm drops below this number, a blood lactate prick will be taken and the VO2 max 
test is over. You may then take a break and hydrate.  
o The wattage achieved in your last fully completed 60-second interval will be used 
to calculate the intensities for the high intensity intervals.  
The length of time (break) between testing will be a minimum of 10 minutes and a 
maximum of 15 minutes; the MOXY and heart rate monitors will remain attached and 
continue monitoring during this break as well.  
After the break and hydration, you will be set up once again on the stationary bike, per 
protocol. The high intensity intervals will then begin.  
You will then undergo a second testing procedure. This will include 6 30-second intervals 
at a high intensity with each being followed by a 90-second interval at a lower intensity. 
You will wear the VO2 mask for this portion as well.  
High intensity protocol (HIIT): The HIIT protocol will consist of 6, 30-second intervals 
at high intensity as well as 6, 90-second recovery intervals at much lower intensities. 
These intervals will be based on the wattages calculated from the VO2 max test. During 
the intervals the MOXY monitors will be placed on both quadriceps muscles as well as 
the left shoulder exactly as they were during the VO2 max test. The heart rate monitor 
will also be used during this portion of the study. Blood lactate will be evaluated at the 
end of each high-intensity 30 second interval by using a finger prick and blood lactate 
analyzer. The percentage of maximum wattage will be as follows:  
o 90 seconds @ 20% max VO2 wattage  
o 30 seconds @ 125% max VO2 wattage 
o 90 seconds @ 20% max VO2 wattage 
o 30 seconds @ 125% max VO2 wattage 




o 30 seconds @ 125% max VO2 wattage 
o 90 seconds @ 20% max VO2 wattage 
o 30 seconds @ 125% max VO2 wattage 
o 90 seconds @ 20% max VO2 wattage 
o 30 seconds @125% max VO2 wattage 
o 90 seconds @20% max VO2 wattage o 
30 seconds @ 125% max VO2 wattage 
o Cool down until you fully recover from the intervals.  
Once the HIIT intervals are complete, the testing for this study is complete. All 
equipment will be taken off and your participation is complete.  
What possible harms or discomforts might I experience if I take part 
in the research?  
There are always risks (the chance of harm) when taking part in research. We know about the 
following risks or discomforts you may experience if you choose to volunteer for this study. These 
are called side effects. The following side effects are known to occur in some people:  
Physical exhaustion 




Shortness of breath  
Discomfort from wearing the VO2 mask  
Gagging on the mouthpiece while performing the testing exercises  
A finger prick will be used to draw blood at 8 different times. Each prick will use a small 
drop of blood to analyze lactate levels. Total blood drawn in 8 pricks will equal less than 
6 needle-size drops of blood. This may briefly sting and may be sore.  
The testing procedure may involve risks to the participants, which are currently 
unknown and unforeseeable  
This study will have no impact on reproductive issues. 
 
There is always a chance that you may experience some discomfort or harm when taking part in a 
research study, this study is no different. We will do everything possible to keep you from being 
harmed. There may be other risks or side effects that occur which we do not know about at this 
time. 
 
It is important for you to tell us as quickly as possible if you experience any discomfort, harm 
or side effect as a result of taking part in this study. 
 
Are there any reasons I might want to withdraw from the research 
or you might take me out of the research? 
 
There may be reasons we would need to take you out of the study, even if you want to stay in the 
study. Some of these reasons include: 
It is not safe for you to stay in the study;  





If we find that the research might harm you or that it is not providing enough of a benefit to 
justify the risks you are taking, we will stop testing immediately. Any data we had obtained up 
until that point will be made available to you upon request. If you would like a copy of the data, 
simply ask the principal investigator for a copy. They will then write down your data on a piece of 
paper and seal it in an envelope and personally give it to you. 
 
What are the possible benefits I may experience from taking part in 
this research?  
We do not know if you will benefit by taking part in this study. Other people who have taken part 
in this study have experienced learning about their VO2 max, muscle oxygen patterns, 
resting/exercising heart rate and exercising blood lactate. This may be of interest to you as it 
reflects your current fitness training level. By participating in this research study, you may also 
experience these benefits. 
 
Will I be paid for taking part in this research? 
We will not be able to pay you for the time you volunteer while being in this study. 
 
What will it cost me to take part in this research?  
It will not cost you any money to be part of the research. 
 
Who will know that I took part in this research and learn 
personal information about me?  
To do this research, ECU and the people and organizations listed below may know that you took 
part in this research. They may also see information about you that is normally kept private. With 
your permission, these people may use your private information to do this research:  
The research team, including the Principal Investigator, study coordinator, and all 
other research staff.  
All of the research sites’ staff. This includes the research and medical staff at each site.  
Any agency of the federal, state, or local government that regulates this research. This may 
include the Department of Health and Human Services (DHHS), the Food and Drug 
Administration (FDA), the North Carolina Department of Health, and the Office for Human 
Research Protections  
The ECU University & Medical Center Institutional Review Board (UMCIRB) and the staff 
who have responsibility for overseeing your welfare during this research;  
ECU office staff who oversee this research.  
How will you keep the information you collect about me secure and how 
long will you keep it?  
The data will be kept secure on a web-based drive as well as a metabolic cart located in the Human 
Performance Laboratory (HPL) lab and will be stored for 3 years. The data will be coded and 
secure so that no one except the PI can access it. The data will only be released if the participant 
wants to know their own data. If the subject does wish to know, the data will be sealed in an 







What if I decide I do not want to continue in this research? 
Taking part in this study is voluntary. If you decide you no longer want to be in this research after 
it has started, you may stop at any time. You will not be penalized or criticized for stopping. You 
will not lose any benefits that you should normally receive by quitting. 
 
What if I get sick or hurt while I am in this research? 
 
If you need emergency care:  
Call 911 for help. It is important that you tell the doctors, the hospital or emergency room staff that 
you are taking part in a research study and the name of the Principal Investigator. If possible, take a 
copy of this consent form with you when you go. 
 
Call the principal investigator as soon as you can. He/she needs to know that you are hurt or ill. 
Call Justin Simmons (804) 244-1263 or Dr. Laurel Wentz at (717) 870-9082. 
 
If you do NOT need emergency care, but have been hurt or get sick: 
Contact Justin Simmons at (804) 244-1263.  
Call the principal investigator as soon as you can. As necessary, go to your regular doctor. It is 
important that you tell your regular doctor that you are participating in a research study. If 
possible, take a copy of this consent form with you when you go. 
 
If necessary, the Principal Investigator or your regular doctor can assist you in identifying 
the appropriate place to get care. 
 
If you are harmed while taking part in this study: 
 
If you believe you have been hurt or become sick because of something that is done during the 
study, you should contact the PI, Justin Simmons, immediately. There are procedures in place to 
help attend to your injuries or provide care if needed. Researchers are both CPR and blood 
pathogen certified in case of emergency during your testing. The proper authorities including 
911 will be contacted for immediate assistance if necessary. 
 
Who should I contact if I have questions? 
The people conducting this study will be available to answer any questions concerning this 
research, now or in the future. You may contact the Principal Investigator, Justin Simmons any day 
at (804) 244-1263. (nights and weekends). 
 
If you have questions about your rights as someone taking part in research, you may call the ECU 
Office of Research Integrity & Compliance (ORIC) at phone number 252-744-2914 (days). If you 
would like to report a complaint or concern about this research study, you may call the Director 
of ORIC, at 252-744-1971 
 
I have decided I want to take part in this research. What should I do 
now?  
The person obtaining informed consent will ask you to read the following and if you agree, 
you should sign this form: 
 
I have read (or had read to me) all of the above information. 
 
59 
I have had an opportunity to ask questions about things in this research I did 
not understand and have received satisfactory answers.  
I understand that I can stop taking part in this study at any time.  
By signing this informed consent form, I am not giving up any of my rights. 





Participant's Name (PRINT) Signature Date 
 
 
I have conducted the initial informed consent process. I have orally reviewed the contents of 
the consent document with the person who has signed above and answered all of the person’s 

















































The Assessment of Muscle Oxygen Saturation in Students During Maximal VO2 Exercise and 
High Intensity Intervals  
Physical Training History 
1. How long have you been in the ROTC program?  
a) 0-1yr  
b) 2yr  
c) 3yr  
d) 4yr  
e) I am not in the ROTC program 
 
2. How long have you been performing endurance training at least 3+ days/ week for 
30min or more for each workout?  
a) <1yr  
b) 1-2yrs  
c) 2-3yrs  
d) 3-4yrs  
e) >4yrs  
f) I do not perform endurance training at least 30 minutes 3 times per week 
 
3. How many miles per week on average do you run?  
a. I do not run  
b. 0-5miles  
c. 5-10miles  
d. 10-15miles  
e. 15-20 miles  
f. 20+ miles 
 
4. Have you had any training related injuries within the last 12months?  




5. Have you ever taken an exercise course in school?  
a. Yes  
b. No 
 
6. On a scale of 1-10 with 10 being the least prepared and 10 being the most prepared, how 
well do you believe the ROTC training program prepares you for physical fitness testing 
and overall soldier physical readiness? (Put N/A if you are not in the ROTC program) 
 _______  
7. Do you currently have or ever had a heart related condition or bleeding disorder? 
 ____ Yes ____No 
8. Have you had a musculoskeletal injury within the last 3 months? 
 ____ Yes ____No 
9. Are you between the ages of 18 and 30 years? 
 ____ Yes ____No 
 
Subject ID: _____________________ 
 




In the past month, how often did you take the following dietary supplements?  
For each category, examples are provided but are  Never 1 time 2-3 1 time 2-3 Every 
not all-inclusive   per times per times day 
   month per week per  
    month  week  
Multivitamin (Centrum, One-a-Day, Mega-Men,        
etc.)        
        
Vitamin D (vitamin D2 or D3)        
        
Individual vitamins and/or minerals (vitamin C,        
vitamin E, B-complex, zinc, magnesium, etc.)        
Fish oil (containing omega-3 such as EPA/DHA)        
        
Protein powders (whey, casein, soy)        
        
Creatine, HMB (hydroxymethyl butyrate)        
        
Amino acids (branched chain amino acids,        
leucine, glutamine, beta-alanine, arginine)        
SARM’s (Selective Androgen Receptor Modulator:        
Enobosarm, Triple Stack, Ostarine, S-4, Andarine)        
Testosterone Pro-hormones/Boosters (DMZ,        
ZMA, tribulus, dimethazine, methylsten,        
androstenedione, DHEA)        
Pre-workout stimulants (Jack3d, Superpump, NO        
Xplode, NO2 enhancers, Cellucor, Hemo Rage        
Black, Muscle Warfare, Naplam, Nitric Blast, etc.)        
Thermogenics/weight loss aids (Hydroxycut,        
Oxyelite, Thermoburst Hardcore, Lipo-6, Burn 60,        
RoxyLean, SlimQuick, Xenadrine, Ephedra, Green        
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tea extract, etc.)  
Energy drinks (Red Bull, Monster, 5-hr energy,  
Rip It, Rock Star, etc.)  
Melatonin 
 
Herbs (fenugreek, milk thistle extract, saw 
palmetto, echinacea, ginkgo biloba, turmeric, 
ginger extract, St. John’s wort, flaxseed, etc.)  
Joint Formulas (Glucosamine, chondroitin) 
 
Carbohydrates/Electrolyte Formulas (Endurox, 
Hammer products, Accelerade, Gatorade,  
Powerade Right Stuff, UCAN, Gu gels etc.)  













In the past month, how often did you eat/drink each of the following foods?  
Only a few examples from each category are listed, Rarely or 1-2 3-6 1 serving 2-3 4 or more 
but more foods are available 
never servings servings per day servings servings 
 per week per week  per day per day 
   
FRUIT: fresh, frozen, canned, dried, 100% fruit juice.       
1 serving = 1 cup of fruit, ½ cup fruit juice       
VEGETABLES: fresh, frozen, canned, cooked, or       
raw.       
1 serving = 1 cup of raw vegetables, ½ cup of cooked       
vegetables       
WHOLE GRAINS: whole wheat bread, pasta, brown       
rice, rye, oatmeal, corn tortillas       
1 serving = 1 slice of bread, ½ cup of grains       
DAIRY PRODUCTS: milk, yogurt, cottage cheese,       
deli cheese, ice cream/frozen yogurt       
1 serving = 8 oz. liquid, 1 oz. of cheese, ½ cup ice       
cream       
 
In the past month, how often did you have each of the following foods?  
Rarely or 1 time per 2 times 1 time per 2-3 times 4 or more 
never month per month week per week times per 







Poultry (chicken, turkey) 
 
Lunch meats (i.e., deli meats) 
 
Pork (pork, ham, sausage, bacon)  




Please answer the following questions regarding your current exercise regimen  
How often do you exercise? 
 
What type of exercising are you doing? 
(Crossfit-style, weightlifting, cardio, etc.) 
 
 
How long are you exercising per session? 
 
 
On a scale of 1-5, what is the intensity of 
your usual workout? (1-Leisure walking, 




































Appendix D: Additional Tables and Figures for Remaining Participants 
 
Figure 1d. Participant 001 SmO2 (%) and total hemoglobin (g/dL) in the left and right 
quadriceps across time 
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Table 7d. Participant 001. SmO2 and Total Hemoglobin 
 Subject #001 S SmO2 L SmO2 R SmO2 S THb L THb R THb 
  (%) (%) (%) (g/dl) (g/dl) (g/dl) 
  Start/En Start/En Start/End Start/End Start/End Start/End 
  d d     
 Interval 1 79/72 76 79/66 11.7/11.7 11.2/11.4 11.4/11.4 
 Interval 2 75/70 65 77/66 11.7/11.6 11.2 11.6/11.4 
 Interval 3 78/71 79 80/65 11.7/11.6 11.4 11.6/11.3 
 Interval 4 80/76  82/70 11.8/11.6  11.7/11.4 
 Interval 5 83/76 87 82/72 11.8/11.6 11.5 11.7/11.3 
 Interval 6 82/76 71 83/73 11.8/11.6 11.3 11.6/11.3 
 Avg Change -6%  -11.8% -.11  -.25 
 Per Interval       
 
Figure 1e. Participant 005. SmO2 (%) and total hemoglobin (g/dl) in the left and right 
quadriceps across time 
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Table 7e. Participant 005. SmO2 and Total Hemoglobin 
 
  Deltoid Left  Quad Right Left Right  Quad  
  SmO2 SmO2 (%) Quad Quad THb 
.   (%) Start/End SmO2 (%) THb Start/End 
   
  Start/End  Start/End (mg/dl) (mg/dl)  
     Start/End Start/End  
 Interval 1 87/86 99/98 90/73 11.7/9.8 11.9/11.4  
 Interval 2 87/78 97/78 90/45 11.8/10.7 11.9/11.4  
 Interval 3 87/85 97/97 87/53 11.7/9.9 11.9/11.4  
 Interval 4 86/85 96/58 89/56 11.8/10.3 12.0/11.4  
 Interval 5 87/82 95/96 89/58 11.8/11.0 12.1/11.4  
 Interval 6 89/77 96/96 89/57 11.8/9.9 12.0/11.4  
 Avg Change -5% -9.5% -32% -1.5 -.6 mg/dl  
 Per Interval    mg/dl   


























Figure 1f. Participant 006. SmO2 (%) and total hemoglobin (g/dL) in the left 
and right quadriceps across time 
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Table 7f. Participant 006. SmO2 and Total Hemoglobin 
  Deltoid Left  Quad Right Quad Left Quad THb Right Quad THb 
  SmO2 (%) SmO2 (%) SmO2 (%) (mg/dl) Start/End 
  Start/End Start/End Start/End Start/End  
       
 Interval 1 86/89 96/97 /99 11.85/11.58 /11.80 
 Interval 2 80/80 95/96 98/99 11.88/11.46 12.0/ 
 Interval 3 79/79 94/96 97/99 11.89/11.44 11.98/11.60 
 Interval 4 81/83 93/96 96/99 11.88/11.54 11.97/11.69 
 Interval 5 85/84 93/95 96/98 11.88/11.55 11.95/11.71 
 Interval 6 83/84 94/96 96/98 11.9/11.58 11.96/11.75 
 Avg  Change +.83% +1.8% +1.7% +1.7 mg/dl -.31 mg/dl 
 Per Interval      






Table 8d. Participant 001. Interval Ending Measurements 
Interval SmO2 SmO2 SmO2 Blood Heart VO2 %VO2 
# S(%) L(%) R(%) Lactate Rate (ml/kg/min) Max 
    (mmol/l) (bpm)   
1 70  66 7.2 182 20.0 51.7 
2 68  64 8.9 190 23.9 61.8 
3 71  64 9.2 194 21.8 56.3 
    67    
4 74 69 10.3 194 28.8 74.4 
5 74 71 8.3 195 28.0 72.3 
6 73 72 9.8 196 28.8 74.4  
Blank spaces indicate unavailable data 
 
 
Table 8e. Participant 005. Interval Ending Measurements 
 Interval SmO2 SmO2 SmO2 Blood Heart VO2 %   VO2 
 # S(%) L(%) R(%) Lactate Rate (ml/kg/min) Max 
    (mmol/l) (bpm)   
 1 84 98  11.9 180 43.1 81.5 
 2 75 78 55 13.1 180 43.8 82.8 
 3 84  53 15.3 182 44.3 83.7 
 4 85 96 57 15.3 183 45.1 85.3 
 5 81  58  182 44.5 84.1 
 6 74  58 15.1 182 43.5 82.2 
 Blank spaces indicate unavailable data     
 Table 8f. Participant 006. Interval Ending Measurements    
 Interval SmO2 SmO2 SmO2 Blood Heart VO2 %VO2 
 # S(%) L(%) R(%) Lactate Rate (ml/kg/min) Max 
    (mmol/l) (bpm)   
 1 86 96 99  168 29.0 67.8 
 2 76 96 99  172 32.7 76.4 
 3 75 96  12.8 170 31.5 73.6 
 4 81 96 99  170 31.6 73.8 
 5 84 96 98 12.0 167 30.8 72.0 
 6 81 96 98 11.6 168 31.4 73.4  


























Figure 2d. Participant 001. SmO2 (%) of the left and right quadriceps and VO2 (ml/kg/min) 
across time.  
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Figure 2e. Participant 005. SmO2 (%) of the left and right quadriceps and VO2 (ml/kg/min) 
across time 
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Figure 2f. Participant 006. SmO2 (%) of the left and right quadriceps and VO2 (ml/kg/min) 
across time 
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Figure 3d. Participant 001. SmO2 (%) of the left and right quadriceps and heart rate 
(bpm) during the six high-intensity intervals. 
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Figure 3e. Participant 005. SmO2 (%) of the left and right quadriceps and heart rate (bpm) 
during the six high-intensity intervals. 
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Figure 3f. Participant 006. SmO2 (%) of the left and right quadriceps and heart rate 
(bpm) during the six high-intensity intervals. 
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Table 9d. Participant 001. Blood Lactate Taken at the 
End of Each Interval  
 L SmO2 R SmO2 BL 
 (%)  (%) (mmol/l) 
 Start/End Start/End   End 
 Interval 1 76  79/66 7.2  
 Interval 2 65  77/66 8.9  
 Interval 3 79  80/65 9.2  
 Interval 4   82/70 10.3  
 Interval 5 87  82/72 8.3  
 Interval 6 71  83/73 9.8  
 Blank spaces indicate unavailable data 
 Table 9e. Participant 005. Blood Lactate Taken at the 
 End of Each Interval     
  Left Quad Right Quad Blood Lactate 
  SmO2 SmO2 (%) (mmol/l) 
  (%) Start/End End 
  Start/End     
 Interval 1 99/98 90/73 11.9  
 Interval 2 97/78 90/45 13.1  
 Interval 3 97/97 87/53 15.3  
 Interval 4 96/58 89/56 15.3  
 Interval 5 95/96 89/58   
 Interval 6 96/96 89/57 15.1  
       
 
 
Table 9f. Participant 006. Blood Lactate Taken at the 
End of Each Interval  
  Left  Quad Right Quad Blood Lactate 
  SmO2 (%) SmO2 (%) (mmol/l) 
  Start/End Start/End End 
     
 Interval 1 96/97 99  
 Interval 2 95/96 98/99  
 Interval 3 94/96 97/99 12.8 
 Interval 4 93/96 96/99  
 Interval 5 93/95 96/98 12.0 
 Interval 6 94/96 96/98 11.6 
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